Clinical Trial

A Study of GC203 TIL in Advanced Solid Tumors (NF)

Name: A Study of GC203 TIL in Advanced Solid Tumors (NF) — clinical trial record (NCT07256756)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is a prospective, open-label, single-arm clinical trial aimed at evaluating the safety and efficacy of GC203 TIL therapy in treating malignant solid tumors that have failed standard treatment.

Protocol Amendment History 1 change

critical Recruitment opened 2026-08-06

Trial Details

NCT Number	NCT07256756
Lead Sponsor	Shanghai Juncell Therapeutics Collaborators: Shenzhen Hospital of Southern Medical University
Conditions	Solid Tumors, Adult
Enrollment	8 participants
Start Date	2026-01-30
Primary Completion	2026-11-30 (estimated)
Study Completion	2028-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-05